GlassScriptPhysician profile
Andrew L Mcelroy
NPI 1578095766
$3,741.70
in general payments reported to CMS, 2019-2025
35 companies · $1,453 in 2025
The $1,453 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $294 · 2021: $144 · 2022: $150 · 2023: $693 · 2024: $773 · 2025: $1,453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,834 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,833.65 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $848.91 | 2019-2025 | Rezum Generator, Spaceoar Vue System - 10ml, Lithovue |
| Coloplast Corp | $217.88 | 2023-2025 | Speedicath |
| Astellas Pharma US INC | $206.85 | 2023-2025 | Xtandi |
| Teleflex LLC | $203.66 | 2022-2025 | Barrigel, Urolift |
| Medtronic, INC. | $200.72 | 2023-2025 | Interstim |
| Sumitomo Pharma America, INC. | $188.24 | 2023-2025 | Orgovyx, Gemtesa |
| Procept Biorobotics Corporation | $161.86 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Abbvie INC. | $153.55 | 2024-2025 | |
| Antares Pharma, INC. | $148.75 | 2023-2025 | Xyosted, Tlando, Nocdurna |
| Urogen Pharma, INC. | $143.10 | 2024-2025 | |
| Calyxo, INC. | $137.87 | 2024-2025 | Cvac Aspiration System |
| Endo USA, INC. | $137.85 | 2024-2025 | Xiaflex, Aveed |
| Astrazeneca Pharmaceuticals LP | $128.43 | 2025 | Lynparza, Onglyza |
| Amgen INC. | $105.63 | 2019 | |
| Myriad Genetic Laboratories, INC. | $72.82 | 2023-2024 | Prolaris |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $69.74 | 2023-2024 | |
| Accord Healthcare, INC. | $63.64 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $58.79 | 2024-2025 | |
| Verity Pharmaceuticals INC. | $57.95 | 2023-2025 | Trelstar |
| Laborie Medical Technologies Corp. | $52.59 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Axonics, INC. | $44.86 | 2023-2024 | Axonics |
| Olympus America INC. | $39.46 | 2024 | Itind System |
| Dendreon Pharmaceuticals LLC | $30.27 | 2025 | Provenge |
| Janssen Scientific Affairs, LLC | $29.86 | 2025 | Erleada |
| Blue Earth Diagnostics | $24.86 | 2024 | |
| Progenics Pharmaceuticals, INC. | $24.81 | 2023 | Pylarify |
| Axogen | $24.81 | 2025 | |
| Ferring Pharmaceuticals INC. | $24.09 | 2024 | Adstiladrin |
| Avation Medical, INC. | $23.73 | 2025 | Vivally System |
| Endo Pharmaceuticals INC. | $22.49 | 2023 | Xiaflex, Edex, Aveed |
| Pfizer INC. | $20.00 | 2025 | |
| Karl Storz Endoscopy-America | $19.32 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $18.88 | 2023 | Seglentis |
| Photocure INC | $18.34 | 2024 | Cysview |
| Vertex Pharmaceuticals Incorporated | $17.09 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Mcelroy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.